| scholarly article | Q13442814 |
| P50 | author | Connie Weaver | Q48005905 |
| P2093 | author name string | Leecole L Legette | |
| P2860 | cites work | The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers | Q24653795 |
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year | Q30858301 | ||
| Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women | Q30914141 | ||
| Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial | Q33205929 | ||
| The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones | Q34162974 | ||
| Soy isoflavones and bone health: a double-edged sword? | Q36430647 | ||
| Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. | Q36740613 | ||
| Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca | Q37196774 | ||
| Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. | Q37348346 | ||
| Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. | Q37379505 | ||
| Effect of soy protein on endogenous hormones in postmenopausal women | Q40670829 | ||
| Evolution of the pathogenesis of postmenopausal bone loss. | Q40957440 | ||
| Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol | Q43274797 | ||
| The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. | Q43671000 | ||
| Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study | Q44171640 | ||
| Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta | Q44798276 | ||
| Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. | Q44902201 | ||
| The effect of soy protein isolate on bone metabolism | Q44913646 | ||
| Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial | Q44967448 | ||
| Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats | Q46110105 | ||
| Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures | Q46486650 | ||
| Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes | Q46600240 | ||
| OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration | Q46629667 | ||
| Effects of dietary equol administration on the mammary gland in ovariectomized Sprague-Dawley rats. | Q50683261 | ||
| Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. | Q50776071 | ||
| Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women | Q74352441 | ||
| Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women | Q77664986 | ||
| Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol | Q79859496 | ||
| Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice | Q80822926 | ||
| Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial | Q82874873 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1377S-9S | |
| P577 | publication date | 2010-05-26 | |
| P1433 | published in | Journal of Nutrition | Q3186931 |
| P1476 | title | Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss | |
| P478 | volume | 140 |
| Q40163473 | Commercial rodent diets differentially regulate autoimmune glomerulonephritis, epigenetics, and microbiota in MRL/lpr mice |
| Q37828472 | Diagnosis and treatment of osteopenia |
| Q64922559 | Effects of Equol Supplement on Bone and Cardiovascular Parameters in Middle-Aged Japanese Women: A Prospective Observational Study. |
| Q37905857 | Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist |
| Q57258718 | Extrahepatic Drug-Metabolizing Enzymes and Their Significance |
| Q38032743 | Soyfoods and soybean products: from traditional use to modern applications. |
Search more.